Alira Health

Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services.

News
Category:
Published on:
November 29, 2020

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.

Benvic is a French group leader in the production of highly innovative PVC-based thermoplastic solutions and ecological biopolymers.

For more information, please contact Gabriele Brambilla.

To read the full press release

Click here

Aenean ut neque vehicula, iaculis odio ut, porta risus. In gravida libero faucibus ex vulputate pharetra. Donec sed sapien odio. Donec vel pellentesque eros. Aliquam erat volutpat. Suspendisse luctus massa accumsan, egestas lacus ac, aliquam libero. Praesent mollis magna vel mi fermentum pulvinar. Fusce quis ultricies sapien, eu suscipit ligula. Duis ut enim ac felis scelerisque sodales. Quisque a elit ac mi cursus posuere vitae sed augue. Nunc varius a ex eget posuere. Nullam fringilla aliquet diam. Maecenas mattis ac massa id fermentum. Proin convallis dui sit amet urna volutpat, ac rutrum magna volutpat. Sed gravida tincidunt laoreet. Nulla nec enim vitae nulla vehicula tempus.

Related news

Events February 3, 2025
Technology and Heart Failure Therapeutics Conference 2025
Look for our cardiovascular experts onsite in Boston to discuss your development support needs.
CDMO Medical Devices MedTech
Uncategorized January 23, 2025
The 2025 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2025 and beyond.
CDMO MedTech
Events January 15, 2025
MD&M West 2025
Join our Coffee Talk session “Private Equity Buy-and-Build Strategies in Medtech CDMO” on Tuesday, February 4 at MD&M West.
CDMO Medical Devices MedTech
Reports December 12, 2024
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
Advanced Therapies Biologics CDMO
Articles October 16, 2024
Biologics and Advanced Therapies Contract Manufacturing Industry: Current Trends, Challenges, and Opportunities
Summary of the 2024 Biologics and Advanced Therapies Contract Manufacturing Report including industry performance and outsourcing trends.
Advanced Therapies Biologics CDMO
Uncategorized October 8, 2024
Critical Quality Attributes for Drug Products Preview
In this article, we explore the importance of Critical Quality Attributes in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Biotech CDMO Drug Development
News September 23, 2024
Alira Health Releases 2024 Biologics and Advanced Therapies CDMO Market Report Amid Continued Macro-Economic Uncertainty
Despite market contraction in 2023, strategic interest in biologics and advanced therapies remains robust, with a rebound expected by 2025.
Biologics CDMO
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.